Virtual Medicinal Product (VMP) - Decitabine 35mg / Cedazuridine 100mg tablets
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Current Name | Decitabine 35mg / Cedazuridine 100mg tablets | 28-11-2023 |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- Other
Codes
- ATC Code
- L01BC58
- BNF Codes
-
- BNF code 08010300
Code | Start Date | End Date |
---|---|---|
42476911000001102 | 28-11-2023 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Cedazuridine | Based on Ingredient Substance | 100 mg | ||
Decitabine | Based on Ingredient Substance | 35 mg |
Name
Decitabine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
35.0
Strength and UOM (Dmr)
Name
Cedazuridine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100.0
Strength and UOM (Dmr)
Parent Products
-
VTMDecitabine + Cedazuridine
-
VMP(Current) Decitabine 35mg / Cedazuridine 100mg...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
5 tablet |